Phase I trial of cisplatin, pemetrexed, and imatinib mesylate in chemonaive patients with unresectable malignant pleural mesothelioma.
about
Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesPhase I Trial of Cediranib in combination with cisplatin and pemetrexed in chemo naive patients with unresectable malignant pleural mesothelioma (SWOG S0905).A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma.Novel systemic therapy against malignant pleural mesothelioma.Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma.
P2860
Phase I trial of cisplatin, pemetrexed, and imatinib mesylate in chemonaive patients with unresectable malignant pleural mesothelioma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase I trial of cisplatin, pe ...... alignant pleural mesothelioma.
@en
Phase I trial of cisplatin, pe ...... alignant pleural mesothelioma.
@nl
type
label
Phase I trial of cisplatin, pe ...... alignant pleural mesothelioma.
@en
Phase I trial of cisplatin, pe ...... alignant pleural mesothelioma.
@nl
prefLabel
Phase I trial of cisplatin, pe ...... alignant pleural mesothelioma.
@en
Phase I trial of cisplatin, pe ...... alignant pleural mesothelioma.
@nl
P2093
P2860
P1433
P1476
Phase I trial of cisplatin, pe ...... alignant pleural mesothelioma.
@en
P2093
Anne S Tsao
J Jack Lee
Junya Fujimoto
Katherine Pisters
Nusrat Harun
Waun Ki Hong
P2860
P304
P356
10.1016/J.CLLC.2013.12.008
P407
P577
2013-12-27T00:00:00Z